Kalvista Issuance Of Capital Stock from 2010 to 2024
| KALV Stock | USD 11.08 0.22 1.95% |
Issuance Of Capital Stock | First Reported 2010-12-31 | Previous Quarter 50.9 M | Current Value 58.6 M | Quarterly Volatility 46.7 M |
Check Kalvista Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kalvista main balance sheet or income statement drivers, such as Depreciation And Amortization of 403.2 K, Interest Expense of 0.0 or Selling General Administrative of 4.6 M, as well as many exotic indicators such as Price To Sales Ratio of 12.41, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0407. Kalvista financial statements analysis is a perfect complement when working with Kalvista Pharmaceuticals Valuation or Volatility modules.
Kalvista | Issuance Of Capital Stock |
Latest Kalvista Pharmaceuticals' Issuance Of Capital Stock Growth Pattern
Below is the plot of the Issuance Of Capital Stock of Kalvista Pharmaceuticals over the last few years. It is Kalvista Pharmaceuticals' Issuance Of Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kalvista Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Issuance Of Capital Stock | 10 Years Trend |
|
Issuance Of Capital Stock |
| Timeline |
Kalvista Issuance Of Capital Stock Regression Statistics
| Arithmetic Mean | 78,622,611 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 59.40 | |
| Mean Deviation | 28,739,452 | |
| Median | 87,910,000 | |
| Standard Deviation | 46,705,277 | |
| Sample Variance | 2181.4T | |
| Range | 210.6M | |
| R-Value | (0.25) | |
| Mean Square Error | 2206.7T | |
| R-Squared | 0.06 | |
| Significance | 0.38 | |
| Slope | (2,571,613) | |
| Total Sum of Squares | 30539.4T |
Kalvista Issuance Of Capital Stock History
About Kalvista Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Kalvista Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Kalvista Pharmaceuticals investors use historical funamental indicators, such as Kalvista Pharmaceuticals's Issuance Of Capital Stock, to determine how well the company is positioned to perform in the future. Although Kalvista Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Kalvista Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Kalvista Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Kalvista Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Kalvista Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Issuance Of Capital Stock | 50.9 M | 58.6 M |
Pair Trading with Kalvista Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kalvista Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kalvista Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Kalvista Stock
| 0.76 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.66 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
Moving against Kalvista Stock
| 0.49 | MRK | Merck Company Financial Report 6th of August 2024 | PairCorr |
| 0.43 | BSGM | Biosig Technologies | PairCorr |
The ability to find closely correlated positions to Kalvista Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kalvista Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kalvista Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kalvista Pharmaceuticals to buy it.
The correlation of Kalvista Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kalvista Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kalvista Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kalvista Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Kalvista Pharmaceuticals Correlation against competitors. For more information on how to buy Kalvista Stock please use our How to Invest in Kalvista Pharmaceuticals guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Kalvista Stock analysis
When running Kalvista Pharmaceuticals' price analysis, check to measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Kalvista Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kalvista Pharmaceuticals. If investors know Kalvista will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kalvista Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.12) | Revenue Per Share 0.214 | Quarterly Revenue Growth 0.307 | Return On Assets (0.42) | Return On Equity (0.79) |
The market value of Kalvista Pharmaceuticals is measured differently than its book value, which is the value of Kalvista that is recorded on the company's balance sheet. Investors also form their own opinion of Kalvista Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kalvista Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kalvista Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kalvista Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kalvista Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kalvista Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kalvista Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.